Share on StockTwits

Analysts at Deutsche Bank raised their target price on shares of Shire PLC (LON:SHP) from GBX 3,920 ($65.90) to GBX 4,350 ($73.13) in a research report issued to clients and investors on Tuesday. The firm currently has a “buy” rating on the stock. Deutsche Bank’s target price points to a potential upside of 21.31% from the company’s current price.

SHP has been the subject of a number of other recent research reports. Analysts at Credit Suisse reiterated a “neutral” rating on shares of Shire PLC in a research note on Monday, June 2nd. They now have a GBX 3,400 ($57.16) price target on the stock. Separately, analysts at Barclays reiterated an “overweight” rating on shares of Shire PLC in a research note on Wednesday, May 21st. They now have a GBX 3,600 ($60.52) price target on the stock. Finally, analysts at Societe Generale reiterated a “buy” rating on shares of Shire PLC in a research note on Tuesday, May 13th. They now have a GBX 4,010 ($67.42) price target on the stock. One analyst has rated the stock with a sell rating, seven have given a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Shire PLC has a consensus rating of “Buy” and an average target price of GBX 2,863.11 ($48.14).

Shares of Shire PLC (LON:SHP) traded up 0.17% during mid-day trading on Tuesday, hitting GBX 3591.9998. 1,107,545 shares of the company’s stock traded hands. Shire PLC has a 1-year low of GBX 1978.0001 and a 1-year high of GBX 4133.00. The stock has a 50-day moving average of GBX 3366. and a 200-day moving average of GBX 3090.32. The company’s market cap is £20.988 billion.

Shire plc (LON:SHP) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.